Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Postoperative Period × 30 days × Clear all

Sponsor

Conditions

Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1

Interventions

X-Rays 4 Specimen Handling 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Biopsy 4 Nuclear Medicine Department, Hospital 3 tazemetostat 2 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 LY3023414 2 ulixertinib 1 tipifarnib 1 pegfilgrastim 1 palbociclib 1 olaparib 1 lutetium Lu 177 dotatate 1 larotrectinib 1 ivosidenib 1 elacestrant 1 decitabine and cedazuridine drug combination 1 cabozantinib 1 alectinib 1 abemaciclib 1 Vemurafenib 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Respiratory Function Tests 1 RAD1901 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡